NEW YORK (GenomeWeb News) – Olink Bioscience and Abnova have agreed to a co-development and co-marketing partnership for protein assays, Olink said today.

Under the agreement, the companies will jointly market hundreds of target-specific assays, and will combine Abnova's collection of antibodies with Olink's Duolink product line. The companies will market the products jointly and each company will handle the sales for its own products, Olink said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.